Literature DB >> 11247867

Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.

M A González-Gay1, C Garcia-Porrua, M J Rivas, P Rodriguez-Ledo, J Llorca.   

Abstract

OBJECTIVE: In Europe giant cell arteritis (GCA) is more common in Scandinavian countries than in southern regions. Epidemiological studies on GCA in other more distant countries have indicated a progressive increase in incidence. A regular cyclical pattern in incidence of GCA over 20 years has been reported in Olmsted County (Minnesota, USA). In contrast, no cyclical fluctuation has been recently reported in Sweden. To investigate further the epidemiology of GCA in southern Europe the trend in incidence and fluctuations of this vasculitis over 18 years in the Lugo region of northwestern Spain were examined.
METHODS: A retrospective study of biopsy proven GCA diagnosed between 1 January 1981 and 31 December 1998 at a single hospital for a well defined population of almost 250 000 people. Annual incidence was calculated for the whole group of patients and for men and women separately. Monthly variations, annual peaks of incidence, and trend in the incidence of biopsy proven GCA with and without polymyalgia rheumatica (PMR) were also examined.
RESULTS: One hundred and sixty one Lugo residents were diagnosed with biopsy proven GCA between 1981 and 1998. The average annual incidence for the population aged 50 and older was 10.24/100 000 (men 11.00/100 000, women 9.57/100 000). A progressive increase in the incidence in both men and women was seen. In men there was an annual increase of 8% (95% CI 4% to 13%; p<0.0001). In women the annual increase was 11% (95% CI 5% to 17%; p<0.0001). The overall annual increase for men and women was 10% (95% CI 6% to 14%; p<0.0001). No seasonal pattern or peaks in the incidence were seen. During the period 1981-94 GCA was more common in men than in women. In contrast, during the last years of study the increase in incidence was higher in women. In women the annual ratio of incidence of GCA with PMR/incidence of GCA without PMR was generally higher than 1. However, in men the annual ratio was initially 1 but decreased gradually, indicating a progressive decrease in the proportion of men with biopsy proven GCA associated with PMR.
CONCLUSION: In northwestern Spain there has been a progressive increase in GCA incidence. As seen in other countries where GCA is more common, during the past few years the increase in incidence has been mainly due to a higher number of new cases in women.

Entities:  

Mesh:

Year:  2001        PMID: 11247867      PMCID: PMC1753598          DOI: 10.1136/ard.60.4.367

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  THE AETIOLOGY, PATHOLOGY AND COURSE OF GIANT-CELL ARTERITIS. THE POSSIBLE ROLE OF LIGHT SENSITIVITY.

Authors:  P D KINMONT; D I MCCALLUM
Journal:  Br J Dermatol       Date:  1965-04       Impact factor: 9.302

2.  The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations.

Authors:  V Petursdottir; H Johansson; E Nordborg; C Nordborg
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

3.  [Epidemiologic approach to Horton's disease in the department of Loire-Atlantique. 110 cases in 10 years (1970-1979)].

Authors:  J Barrier; P Pion; R Massari; P Peltier; J Rojouan; J Y Grolleau
Journal:  Rev Med Interne       Date:  1982-03       Impact factor: 0.728

4.  Temporal arteritis. A 14-year epidemiological, clinical and prognostic study.

Authors:  F Jonasson; J F Cullen; R A Elton
Journal:  Scott Med J       Date:  1979-04       Impact factor: 0.729

5.  Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.

Authors:  M A González-Gay; C García-Porrúa; M Vázquez-Caruncho
Journal:  J Rheumatol       Date:  1998-09       Impact factor: 4.666

6.  The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.

Authors:  B A Bengtsson; B E Malmvall
Journal:  Arthritis Rheum       Date:  1981-07

7.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

8.  Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985.

Authors:  P Boesen; S F Sørensen
Journal:  Arthritis Rheum       Date:  1987-03

9.  Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy.

Authors:  C Salvarani; P L Macchioni; P L Tartoni; F Rossi; R Baricchi; C Castri; F Chiaravalloti; I Portioli
Journal:  Clin Exp Rheumatol       Date:  1987 Jul-Sep       Impact factor: 4.473

10.  Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985.

Authors:  E B Machado; C J Michet; D J Ballard; G G Hunder; C M Beard; C P Chu; W M O'Fallon
Journal:  Arthritis Rheum       Date:  1988-06
View more
  20 in total

Review 1.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

2.  Giant cell arteritis among Hispanic Americans.

Authors:  Byron L Lam; Robert S Wirthlin; Ariadna Gonzalez; Sander R Dubovy; William J Feuer
Journal:  Am J Ophthalmol       Date:  2006-08-28       Impact factor: 5.258

Review 3.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Epidemiology of giant cell arteritis in an Arab population: a 22-year study.

Authors:  Neil R Miller
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

Review 5.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

Review 6.  Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.

Authors:  Jean Schmidt; Kenneth J Warrington
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

7.  Giant cell arteritis in patients of Indian Subcontinental descent in the UK.

Authors:  N Tan; J Acheson; N Ali
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

8.  Giant Cell Arteritis.

Authors:  Jennifer K. Hall; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

9.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

10.  Temporal arteritis: improving patient evaluation with a new protocol.

Authors:  Michael Alberts
Journal:  Perm J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.